Correlation Between Aptose Biosciences and European Residential

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aptose Biosciences and European Residential at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptose Biosciences and European Residential into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aptose Biosciences and European Residential Real, you can compare the effects of market volatilities on Aptose Biosciences and European Residential and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptose Biosciences with a short position of European Residential. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptose Biosciences and European Residential.

Diversification Opportunities for Aptose Biosciences and European Residential

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aptose and European is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Aptose Biosciences and European Residential Real in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on European Residential Real and Aptose Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptose Biosciences are associated (or correlated) with European Residential. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of European Residential Real has no effect on the direction of Aptose Biosciences i.e., Aptose Biosciences and European Residential go up and down completely randomly.

Pair Corralation between Aptose Biosciences and European Residential

Assuming the 90 days trading horizon Aptose Biosciences is expected to under-perform the European Residential. In addition to that, Aptose Biosciences is 2.06 times more volatile than European Residential Real. It trades about -0.38 of its total potential returns per unit of risk. European Residential Real is currently generating about 0.24 per unit of volatility. If you would invest  305.00  in European Residential Real on August 29, 2024 and sell it today you would earn a total of  58.00  from holding European Residential Real or generate 19.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aptose Biosciences  vs.  European Residential Real

 Performance 
       Timeline  
Aptose Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
European Residential Real 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in European Residential Real are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, European Residential sustained solid returns over the last few months and may actually be approaching a breakup point.

Aptose Biosciences and European Residential Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aptose Biosciences and European Residential

The main advantage of trading using opposite Aptose Biosciences and European Residential positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptose Biosciences position performs unexpectedly, European Residential can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in European Residential will offset losses from the drop in European Residential's long position.
The idea behind Aptose Biosciences and European Residential Real pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm